| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.09. | HHS Provides $77M in Grants for Substance Use Prevention, Mental Health | ||
| 01.09. | GSK's Pivotal Test for mRNA Flu Vaccine Aims to Show Two Targets Are Better Than One | ||
| 01.09. | Breaking the Amendment Cycle: How Agentic AI Enables Smarter Clinical Trial Design and Operations | ||
| 01.09. | Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs | ||
| 01.09. | MedCity FemFwd: How Midwives Can Support the Maternal Health Crisis | ||
| 01.09. | 4 Notable Health Tech Funding Announcements in August | ||
| 31.08. | First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder | ||
| 31.08. | AI Won't Transform Health Systems, CEOs Will - 6 Principles to Drive the Transformation | ||
| 30.08. | Hospitals Are All In on AI, but Testing and Oversight Haven't Caught Up | ||
| 30.08. | SK Bio Broadens U.S. Prospects, Licensing Late-Stage Epilepsy Drug From Biohaven | ||
| 30.08. | The Missing Piece in Lowering the Cost of Care: Predictability | ||
| 28.08. | FDA Nod for Inflammation Drug Notches Wins for Rare Disease Patients, Roivant's Biz Strategy | ||
| 28.08. | The Silent Epidemic: Why Diabetic Foot Ulcers Have Been Overlooked for Three Decades | ||
| 28.08. | Reading the Body's Signals: AI's Ultimate Healthcare Opportunity | ||
| 27.08. | AstraZeneca, Amgen Drug Moves Closer to Competing With Dupixent in a New Indication | ||
| 27.08. | Datavant's New Platform Could Cut Record Retrieval Time from Days to Hours | ||
| 27.08. | Precision Medicine Transformed Oncology -It's Time to Do the Same for Sepsis | ||
| 27.08. | What Do the Latest Iteration of Consumer Drug Platforms Offer? | ||
| 26.08. | Onos Health Raises $17M to Expand AI-Powered Behavioral Health Platform | ||
| 26.08. | Cyberattack Disrupts Boston Scientific's Operations: 7 Things to Know | ||
| 26.08. | Revolution Medicines Receives Landmark FDA Drug Approval in Pancreatic Cancer | ||
| 26.08. | Stop Pitching the Institute - Pitch the Stack | ||
| 26.08. | Why Oura's Sleep-Tracking Lawsuit Is Really About Trust | ||
| 26.08. | Business Group on Health: Employer Healthcare Costs Projected to Rise 9.2% in 2027 | ||
| 25.08. | J&J's Imaavy Becomes First FDA-Approved Therapy for Rare Form of Anemia |